Consistent with these theoretical notions, alternative fuels, metabolic supplements and mitochondrial function enhancers have been investigated with the purpose of improving ALS symptoms and delaying disease progression in mouse models of ALS, cell cultures and in patients with ALS
Certainly, an increase in IGF-1 action is associated with greater risk for neoplastic disease, a link further supported by this study and others targeting IGF-1Rs, but IGF-1 has been paradoxically associated with protection against osteoporosis, type 2 diabetes, cerebrovascular and cognitive decline in pre-clinical studies, as well as in some human epidemiologic studies 12
The reason why the drugs should be included in the EML is because there is existing evidence that points to their possible utility in the management of type 2 diabetes particularly when they are undertaken in patients who also have comorbidities such as cardiovascular disease, chronic kidney disease and in cases that are underscored by obesity
Assuming the plateau means the protocol failed
doi: 10.3390/ijms241310985
